Clinical Trial: ECOG-ACRIN EA2186

ECOG-ACRIN EA2186

Status: Closed

A Randomized Phase II Study of Gemcitabine and Nab-Paclitaxel Compared with 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan in Older Patients with Treatment Naive Metastatic Pancreatic Cancer (GIANT)

EA2186 is closed to accrual, effective October 17, 2023.